Boston Scientific has released the primary endpoint results from its NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) clinical trial, the first and only randomized sham-controlled clinical trial investigating vagus nerve stimulation (VNS) for the treatment of heart failure patients. Faiez Zannad, M.D., Ph.D., Professor of Therapeutics and Cardiology and Director of the Clinical Investigation Center at the Institut National de la Sante et de la Recherche Medicale presented the results at the 2014 European Society of Cardiology (ESC) Congress ... read more
The mobile cloud market is fast gaining momentum primarily due to the convenience provided by the mobile cloud apps and services to the users. The present times has seen an extensive rush in the adoption of mobile cloud as it provides users the access to any content simply on a click over one's mobile phone. Further, the mobile cloud market is also growing in pace as users are becoming more responsive towards adapting applications and services pertaining to the mobile ... read more
Royal Philips (NYSE: PHG, AEX: PHIA) today announced the launch of Affiniti, a new ultrasound system designed to enable global hospitals and health systems to overcome the demands of increasing patient volumes and cost pressures. Making its debut at the European Society of Cardiology (ESC) Congress 2014 in Barcelona this week, Affiniti provides innovative technology to help radiology/ultrasound departments facing more patients with fewer resources deliver high quality patient care.
"Affiniti was designed with the everyday challenges of healthcare professionals in ... read more
Today at the European Society of Cardiology congress and published simultaneously in the New England Journal of Medicine, Novartis revealed that its investigational heart failure medicine, LCZ696, was superior to ACE-inhibitor enalapril on key endpoints in the largest heart failure study ever done.(1,7) In PARADIGM-HF, patients with heart failure with reduced ejection fraction (HF-REF) who were given LCZ696 were more likely to be alive and less likely to have been hospitalized for sudden deterioration of their heart failure than those ... read more
Weather you have hundreds of connections, a killer profile and tons of recommendations or you are someone just starting out, making the most of LinkedIn can seem kind of tricky.
Photo - http://photos.prnewswire.com/prnh/20140828/141151
There are some simple ticks you can use to help you easily use LinkedIn to its fullest potential.
1. Import your email contacts.
Chances are you're already connected with those you deal with on a regular basis making this feature is a great way to connect with those who may ... read more
Squibb Company (NYSE:BMY) and Pfizer
Inc. (NYSE:PFE) today announced results of a pre-specified secondary
analysis of the Eliquis Phase 3 AMPLIFY-EXT trial (Apixaban
after the initial Management of PuLmonary embolIsm
and deep vein thrombosis with First-line therapY-EXTended
... read more
Following is the daily "Profile America" feature from the U.S. Census Bureau:
Profile America -- Saturday, August 30th. Few of us have the opportunity to actually change the shape of people's lives and help them to live more happily. Such a man was Dr. Claire Straith, whose birthday in 1891 is noted today. Treating soldiers wounded in World War I, he pioneered many techniques in plastic and cosmetic surgery that are still in use today. Later, noting that he was ... read more
Veeva Systems Inc. (NYSE:VEEV), a leading provider of industry cloud
solutions for the life sciences industry, today announced participation
in the following investor conference:
Citi Global Technology Conference, New York, NY. Matt Wallach,
... read more
Chuma Holdings, Inc. (OTCBB:CHUM) (the "Company"), an entity providing both financing alternatives and turnkey support services for the lawfully organized cannabis industry, is pleased to announce that FINRA processed and approved the Company's name and symbol change request. Effective today, August 29, 2014, CannaMed Corporation will be known as Chuma Holdings, Inc.
The name change was accomplished through a merger with the Company's wholly-owned subsidiary, Chuma Holdings, Inc., that is effective as of today, August 29, 2014. CannaMed Corporation is ... read more
At bariatric facilities like Dr. Feiz and Associates, the life-changing benefits of bariatric surgery, including reduced risk of diabetes, cardiovascular disease and endocrine disorders are well established. After all, Michael Feiz, M.D., F.A.C.S. has successfully treated thousands of patients through bariatric procedures like Lap Band, sleeve gastrectomy and related revision treatments. However, a recent study published in The Journal of Clinical Endocrinology & Metabolism has found that above and beyond these well-known health benefits, bariatric surgery can provide valuable benefits ... read more
Microchip Technology Incorporated (NASDAQ:MCHP)
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN, INTO OR FROM ANY
JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT
LAWS OR REGULATIONS OF SUCH JURISDICTION
... read more
Frontier Communications (NASDAQ:FTR) and the Communications Workers of
America (CWA) announced today that West Virginia locals have ratified
the labor agreement the two parties reached on Aug. 3. The new contract
will expire in August 2017.
“With the CWA ... read more
For years, an unfortunate societal stigma existed that lead many people to feel that it was okay to "shame" those who underwent cosmetic surgery. Thankfully, though, times change, and today we know that even though others may see the beauty within a person, it can be difficult for us to see the beauty within ourselves. There is perhaps no one as aware of the growing acceptance of those who undergo cosmetic liposuction and other surgical procedures than the many health, ... read more
Pure Storage, the all-flash enterprise storage array company, announced
today that it has been positioned in the Leaders Quadrant of the
inaugural Magic Quadrant for Solid-State Arrays (SSA) by Gartner, Inc, a
leading global research firm. The news comes on the heels of Pure
Storage being ... read more
The clinical and medical insights provided by Key Opinion Leaders (KOLs) can be the difference between a product's success or failure. Despite this, many biopharmaceutical organizations struggle to effectively map and stratify KOL targets - and then to coordinate activities and outreach over time to build the type of strong relationships upon which successful KOL engagement rests.
According to recent research, savvy pharma companies have identified internal inconsistencies in their KOL management systems and are working to fill these critical performance ... read more
The Competitive Intelligence (CI) function is evolving in the face of regulatory and marketplace changes. CI leaders who adjust will succeed, and those who don't will flounder.
In a new Best Practices, LLC study CI leaders from 32 biopharmaceutical organizations delivered a host of actionable insights, including:
- Use secondary research whenever possible - it's effective, safer, and cheaper than primary research
- Internal staff who are creative thinkers provide the CI insights that can make a difference
- Conferences & trade shows and ... read more
GRAND RAPIDS, MI--(Marketwired - August 29, 2014) - Agility Health, Inc. (TSX VENTURE: AHI) ("Agility Health" or the "Company"), a leading provider of physical rehabilitation and software services that benefit patients, healthcare providers and employers announces that it has ceased negotiations regarding the acquisition opportunity press released July 21, 2014. The Company believes the decision to not pursue the consummation of the acquisition is in the best interests of the Company and its ... read more
To watch a video that details some of the games coming for Nintendo
systems in 2014 and beyond, visit: https://www.youtube.com/watch?v=HGDH2NsBUw8
The first 12 amiibo interactive figures are now available for pre-order at a suggested retail price of just $12.99 each. (Photo: Business Wire)
Nintendo has ... read more
Pomerantz LLP has filed a class action lawsuit against L-3 Communications Holdings, Inc. ("L-3" or the "Company")(NYSE: LLL) and certain of its officers. The class action, filed in United States District Court, Southern District of New York, and docketed under 14-cv-6038, is on behalf of a class consisting of all persons or entities who purchased L-3 securities between April 25, 2013 and July 30, 2014, inclusive (the "Class Period"). This class action seeks to recover damages against Defendants ... read more